Biospain 2016 – Company Presentation

Biospain 2016 – Company Presentation

Biocross to participate in the 8th International Meeting on Biotechnology, Biospain 2016, which takes place in Bilbao (Vizcaya), September 28–30, 2016. Biospain has become the main scientific, social, commercial, and industrial meeting point of the biotechnological...
Biocross announces AAIC 2016 poster

Biocross announces AAIC 2016 poster

Biocross is pleased to present at the 2016 Alzheimer’s Association International Conference (AAIC) in Toronto its work on the influence of APOE ε4 carrier status on the metabolomic profile of AD patients versus cognitively normal controls. The AAIC is the...
Matthew Mittino, new CEO of Biocross

Matthew Mittino, new CEO of Biocross

Biocross has appointed Matthew Mittino as its new CEO. Biocross is currently developing several projects centered on the diagnosis of Alzheimer’s disease and the identification of populations at risk of developing the disease. Over the last 20 years Matthew’s...